Buprenorphine is a semi-synthetic opioid derived from thebaine. In 1978 it was marketed as an analgesic (pain killer) for post-operative and cancer patients. Later it was reformulated as an effective antidote to opiate Withdrawal. When prescribed just as pure buprenorphine (Subutex), the medication can be abused – crushed and injected or snorted. However, brand names such as Suboxone and ZubSolv, add naloxone (opiate overdose reversal medication) to the formulation to make it abuse resistant and prevent overdoses. However, naloxone in contraindicated for pregnant women and it causes allergic reactions in some people. So, physicians prescribe pure buprenorphine or Subutex.

When individuals who abuse buprenorphine try to stop using abruptly, they experience Withdrawal Symptoms. Withdrawal symptoms for those who inject buprenorphine are usually more severe than for those who snort it. Withdrawal symptoms include nausea, vomiting, headaches, muscle aches, insomnia, lethargy, digestive distress, anxiety, depression, irritability, cravings, fever, and chills.

Individuals who have been prescribed Suboxone or ZubSolv and are taking the medication as prescribed for a period of time in order to stay on the path to recovery from opiate abuse and dependence also will face withdrawal symptoms when they want to come off of Suboxone or ZubSolv. However, the withdrawal symptoms will be milder. In addition, they usually become anxious when trying to quit the medication that has been instrumental in keeping them sober over a period of time. Consequently, coming off of these medications also is best done in a facility with medical monitoring so that the Suboxone/Zubsolv taper can be effectively managed by addressing the emerging mental health issues.

If you are looking for a high-quality suboxone withdrawal management program you have come to the right place. Please call immediately if you or a loved one are experiencing Suboxone withdrawal or buprenorphine withdrawal symptoms.

The post Suboxone Withdrawal, ZubSolv Withdrawal or Buprenorphine Withdrawal Management appeared first on .